This is starting to look a little sad again and there is about a month before the next quarterly. We have had no updates on the KPMG led program or the $7M contract nor much else on the new revenue front for the quarter. Unless an update with some positiveness comes along soon we could be revisiting 15c. The opportunity cost is mounting. This company has enormous potential but it's taking so long!
- Forums
- ASX - By Stock
- AR9
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-78
Featured News
Add AR9 (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.001(1.12%) |
Mkt cap ! $25.76M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.5¢ | $8.63K | 99.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 123529 | 8.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 109324 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 123529 | 0.086 |
2 | 50000 | 0.085 |
1 | 6097 | 0.082 |
7 | 410396 | 0.080 |
1 | 50000 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 109324 | 1 |
0.091 | 88793 | 2 |
0.092 | 307681 | 1 |
0.096 | 24390 | 1 |
0.098 | 25000 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
8.9¢ |
  |
Change
0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
8.7¢ | 8.9¢ | 8.7¢ | 12272 | ||
Last updated 14.31pm 06/05/2024 ? |
Featured News
AR9 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online